1 |
neurofibromatosis type 2
(1235 times)
|
Neurology (270 times)
|
VS (144 times) NF1 (74 times) ABI (53 times)
|
1989 The association of posterior capsular lens opacities with bilateral acoustic neuromas in patients with neurofibromatosis type 2.
|
2 |
neurofibromin 2
(34 times)
|
Neoplasms (15 times)
|
YAP (4 times) RCC (3 times) CGH (2 times)
|
2003 Mutational analysis of the nf2 tumour suppressor gene in three subtypes of primary human malignant mesotheliomas.
|
3 |
neurofibromatosis type 2 tumor suppressor gene
(4 times)
|
Neoplasms (2 times)
|
PAKs (1 time) PKA (1 time)
|
2003 High-resolution profiling of an 11 Mb segment of human chromosome 22 in sporadic schwannoma using array-CGH.
|
4 |
Neurofibromatosis type 2 protein
(3 times)
|
Biology (1 time)
|
IHBDs (1 time) JCV (1 time) T antigen (1 time)
|
2012 Neurofibromatosis type 2 protein, NF2: an uncoventional cell cycle regulator.
|
5 |
NF2 gene
(3 times)
|
Dermatology (1 time)
|
GE-MRI (1 time) MEN (1 time) NEFH (1 time)
|
1993 Germline deletion in a neurofibromatosis type 2 kindred inactivates the NF2 gene and a candidate meningioma locus.
|
6 |
Neurofibromatosis 2 or bilateral acoustic neurofibromatosis
(1 time)
|
Genetics, Medical (1 time)
|
---
|
1990 Flanking markers bracket the neurofibromatosis type 2 (NF2) gene on chromosome 22.
|
7 |
neurofibromatosis 2-related
(1 time)
|
Neurology (1 time)
|
ClinSev (1 time) GenSev (1 time)
|
2014 Longitudinal evaluation of quality of life in 288 patients with neurofibromatosis 2.
|
8 |
Neurofibromatosis Type 2 associated
(1 time)
|
Neoplasms (1 time)
|
BAEP (2 times) AAO-HNS (1 time) BAER (1 time)
|
2021 Risk Stratification for Immediate Postoperative Hearing Loss by Preoperative BAER (Brainstem Auditory Evoked Response) and Audiometry in NF2-Associated Vestibular Schwannomas.
|
9 |
neurofibromatosis type 2-associated meningiomas and schwannomas
(1 time)
|
Antineoplastic Agents (1 time)
|
DLTs (1 time) MTD (1 time) PFS (1 time)
|
2021 A phase 1 trial of the histone deacetylase inhibitor AR-42 in patients with neurofibromatosis type 2-associated tumors and advanced solid malignancies.
|
10 |
neurofibromin2 gene
(1 time)
|
Neoplasms (1 time)
|
miRNAs (1 time) MREs (1 time)
|
2019 MicroRNA‑92a promotes cell proliferation, migration and survival by directly targeting the tumor suppressor gene NF2 in colorectal and lung cancer cells.
|
11 |
NF2 and SMARCB1 genes
(1 time)
|
Molecular Biology (1 time)
|
NF1 (1 time)
|
2018 Clinical and molecular characterization of neurofibromatosis in southern Brazil.
|
12 |
NF2 cause neurofibromatosis type 2
(1 time)
|
Molecular Biology (1 time)
|
---
|
2015 Role of Merlin/NF2 inactivation in tumor biology.
|
13 |
NF2 mutation
(1 time)
|
Neurosurgery (1 time)
|
NF1 (2 times) TS (1 time)
|
2006 Hereditary neurological tumor syndromes: clues to glioma oncogenesis?
|
14 |
NF2+/- mice, a line heterozygous for the tumor suppressor merlin
(1 time)
|
Biological Markers (1 time)
|
CR (1 time) MM (1 time)
|
2018 Absence of calretinin protein expression in malignant mesotheliomas from asbestos-exposed NF2+/- mice and mouse mesothelioma cell lines from various mouse strains.
|
15 |
NF2/merlin underlies neurofibromatosis type 2
(1 time)
|
Molecular Biology (1 time)
|
---
|
2019 The NF2 tumor suppressor merlin interacts with Ras and RasGAP, which may modulate Ras signaling.
|
16 |
None patients had signs ofneurofibromatosis type 2
(1 time)
|
Pathology (1 time)
|
---
|
2008 [Intraneural perineurioma: clinical and morphological characteristics and a molecular genetic study of the neurofibromatosis type 2 gene].
|